IP Library Granted Patent US 7,498,017
Granted Patent B2
US 7,498,017 · App. 11/154,494 · Granted Mar 3, 2009

Compositions for delivering nucleic acids to cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,498,017
App. No.
11/154,494
Granted
Mar 3, 2009
Kind
B2
Abstract

Cyclic amidinium containing compounds and their methods of preparation are described. Compositions containing these compounds facilitate delivery of biologically active polymers to cells in vitro and in vivo.

Claims (14)

1. A process for delivering a polynucleotide to a cell comprising: associating a cationic poly cyclic imidazolinium-containing compound capable of condensing nucleic acid with the polynucleotide to form a complex and contacting the cell with the complex.

2. The process of claim 1 wherein the polynucleotide consists of DNA.

3. The process of claim 1 wherein the polynucleotide consists of RNA.

4. The process of claim 1 wherein the polynucleotide consists of an siRNA.

5. The process of claim 1 wherein the poly cyclic imidazolinium consists of a partially acylated polyethylenimine.

6. The process of claim 5 wherein the partially acylated polyethylenimine consists of an N-propionyl polyethylenimine derivative.

7. The process of claim 5 wherein the polyethylenimine consists of linear polyethylenimine.

8. The process of claim 1 wherein the poly cyclic imidazolinium consists of partially acylated polyallylamine.

9. The process of claim 1 wherein the poly cyclic imidazolinium consists of partially acylated polyvinylamine.

10. The process of claim 1 wherein the cell consists of an in vivo cell.

11. The process of claim 10 wherein the in vivo cell consists of a lung cell.

12. The process of claim 10 wherein the in vivo cell consists of a liver cell.

13. The process of claim 12 wherein the liver cell consists of a hepatocyte.

14. The process of claim 1 further comprising: associating a polyanion with the complex to form a ternary complex having a negative ζ-potential.

Assignments (2)
CHANGE OF NAME Recorded Aug 10, 2009
From: MIRUS BIO CORPORATION
To: ROCHE MADISON INC.
Reel/Frame 023081/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2008
From: TRUBETSKOY, VLADIMIR; MONAHAN, SEAN D
To: MIRUS BIO CORPORATION
Reel/Frame 021556/0074 →